Simponi_referral_form

Simponi ARIA® (golimumab) Referral Form
Patient Information
____________________________________________________________________________________________________________________________________________________________________________________
Last Name
____________________________________________________________________________________________________________________________________________________________________________________ Street Address ____________________________________________________________________________________________________________________________________________________________________________________ Phone (daytime)
____________________________________________________________________________________________________________________________________________________________________________________
Primary Insurance Information
Secondary Insurance Information Pharmacy Insurance Card____
__________________________________________________________________________________________________________________________________________________________________________________ Insurance Name ____________________________________________________________________________________________________________________________________________________________________________________ Cardholder Name ____________________________________________________________________________________________________________________________________________________________________________________ Group / Policy Number
Physician Information
___________________________________________________________________________________________________________________________________________________________________________________
Physician Name
___________________________________________________________________________________________________________________________________________________________________________________ Street Address __________________________________________________________________________________________________________________________________________________________________________________ Physician’s DEA Number
Statement of Medical Necessity : PLEASE INCLUDE A COPY OF CHART DOCUMENTATION OF DIAGNOSIS CODES
Other Rheumatoid Arthritis with visceral or systematic involvement ICD-9 Code: 714.2
Date Diagnosed:________________________________________
Medical History :
Patient Weight: _____(Lbs) / _____(Kgs) Height:__________
Tuberculin (PPD) skin test date_____________ Negative Positive If positive: date of last X-Ray:_________________
Hep B Surface Antigen test date____________ Negative Positive
Allergies:___________________________________________________________________________________________________________________________________________________________________________________________________

Prescription Orders:


Simponi ARIA® (golimumab)

Sig: 2mg/kg intravenous (IV). Infuse over 30 minutes. Infuse day 0, 4 weeks then every 8 weeks.
Pre-medications: Acetaminophen 650 mg PO Benadryl 25mg IVP
Promethazine 25mg IVP Solu-Medrol 40 mg IVP Benadryl 25mg PO Other Premeds Needed __________________________________
Standing lab orders: CMP CBC ESR
CRP other:__________________________ every infusion
Refills: _______times or 12 months.

___________________________________________________________________________________________
Physician’s signature

Fax completed form to (214) 887-0436. Contact us directly at: (214) 276-5642.
Or visit us online at www.ntinfusioncenters.com

Source: http://ntinfusioncenters.info/images/Simponi_Referral_Form.pdf

hausarzt-muenchen-zentrum.de

sie sind an einem sog. „grippalen Infekt“ erkrankt. Hierbei handelt es sich um saisonal auftretenden Virusinfekte, die meist die oberen Atemwege betreffen und einige Tage dauern. Dies sind mildere Krankheitsverläufe als bei der „richtigen Grippe“, diese führt zu mehrtägigem sehr hohen Fieber mit starkem Krankheitsgefühl, im übrigen können Sie sich bei uns gegen Grippe impfen las

Food additives list

O ADDITIVES LIST CODE SUBSTANCE Animal genes damage, possible risk to conception and cancer. Still being evaluated regarding reproductive toxicity. Linked to hyperactivity, skin rashes, migraines, behavioural problems, thyroid problems, chromosome damage. Banned in Norway and Austria. Linked to hyperactivity, skin rashes, asthmatics should avoid. Banned in USA and Norway - previously banne

© 2010-2017 Pdf Pills Composition